Edition:
Deutschland

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

93.33EUR
21 Feb 2020
Change (% chg)

€-0.17 (-0.18%)
Prev Close
€93.50
Open
€93.26
Day's High
€93.69
Day's Low
€92.29
Volume
2,138,010
Avg. Vol
2,075,200
52-wk High
€95.06
52-wk Low
€71.74

About

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality... (more)

Buy/Sell

Sell Hold Buy
1.96 Mean rating from 25 analysts

Overall

Beta: 0.93
Market Cap(Mil.): €108,903.00
Shares Outstanding(Mil.): 1,262.50
Dividend: 2.96
Yield (%): 3.43
Photo

Companies in pharmaceutical supply chain develop system to track counterfeit drugs

NEW YORK Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co , have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday.

Photo

Pharmaceutical companies develop system to better track counterfeit drugs

NEW YORK Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co , have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday.

UPDATE 1-Companies in pharmaceutical supply chain develop system to track counterfeit drugs

NEW YORK, Feb 21 Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co, have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday.

Pharmaceutical companies develop system to better track counterfeit drugs

NEW YORK, Feb 21 Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co, have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday.

Photo

Factbox: Global efforts to develop vaccines, drugs to fight the coronavirus

CHICAGO Researchers and drug companies are scrambling to develop vaccines and treatments to fight the new coronavirus that emerged in central China in December and has spread to more than two dozen countries, killing more than 2,000 people.

FACTBOX-Global efforts to develop vaccines, drugs to fight the coronavirus

CHICAGO, Feb 18 Researchers and drug companies are scrambling to develop vaccines and treatments to fight the new coronavirus that emerged in central China in December and has spread to more than two dozen countries, killing more than 2,000 people.

BRIEF-UK's MHRA Approves Application For Flu Vaccine By Sanofi Pasteur

Feb 19 UK's Medicines and Healthcare products Regulatory Agency:

French and Benelux stocks-Factors to watch

Feb 19 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks. ALTEN SA: French IT services & consulting company Alten reported a full-year operating result up 11.2% at 238.2 million euros. CAPGEMINI SE: Consulting firm Capgemini said it signed an agreement to acquire Scandinavian company Advectas, the leading business intelligence and data science company in Scandinavia.

Photo

Sanofi teams up with U.S. agency against coronavirus

PARIS French drugmaker Sanofi is working with a U.S. government agency to develop a vaccine against the new coronavirus from China, saying it could have a candidate ready for clinical trials within a year.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.02%
Rohstoffe -0.42%
Industrie -0.99%
Konjunktur abhängige Waren & Dienstleistungen +0.23%
Konjunktur unabhängige Waren & Dienstleistungen -0.37%
Finanzindustrie +0.00%
Pharma -1.99%
Technologie +0.37%
Telekommunikation +0.17%